Med-IQ CME: HCM Management and SPEED: Suspicion, Early Intervention, Echocardiography, and Diagnosis
In this accredited CME/CNE activity, cardiologist Dr. Matthew Martinez reviews key considerations and updates in the diagnosis and management of hypertrophic cardiomyopathy (HCM). Specifically, he explores the disease burden and the dire consequences of undiagnosed HCM, the difficulty in diagnosing HCM including lack of symptoms or presence of nonspecific symptoms, best practices for ordering echocardiograms, and guideline recommendations for treatment, including mavacamten. The informational session also discusses communicating with patients and caregivers/families.
Cost: Free
View Offer chevron_rightKey Features
Matthew Martinez, MD, reviews key considerations and updates in the diagnosis and management of hypertrophic cardiomyopathy (HCM) including:Disease burden and the dire consequences of undiagnosed HCM, difficulty in diagnosing HCM, including lack of symptoms or presence of nonspecific symptoms, best practices for ordering echocardiograms, and guideline recommendations for treatment, including mavacamten.
Topics Covered
HCM Diagnosis and Treatment
Learning Objectives
1. Summarize new HCM guidelines and the latest clinical and real-world data regarding oHCM and the use of mavacamten
2. Integrate methods for the early, accurate diagnosis of oHCM
3. Employ methods for improving the use of echocardiography to diagnose oHCM
Target Audience
This activity is intended for cardiologists, nurse practitioners, physician assistants, nurses, echocardiographers, and other clinicians who provide care for people with HCM.
Additional credit info
Med-IQ designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Med-IQ is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
This nursing activity offers a maximum of 1.0 contact hour.